Source: Eur Respir J, 53 (4) 1801727; 10.1183/13993003.01727-2018



Rating:

Share or cite this content

Citations should be made in the following way:
Michael D. Parkins, Kathleen J. Ramos, Christopher H. Goss, Ranjani Somayaji. Cytomegalovirus: an unrecognised potential contributor to cystic fibrosis disease progression?. Eur Respir J, 53 (4) 1801727; 10.1183/13993003.01727-2018

Member's Comments

No comment yet.

Related content which might interest you: Idiopathic pulmonary fibrosis: another step in understanding the burden of this disease Source: Eur Respir J 2016; 48: 26-28 Year: 2016 Monitoring early lung disease in cystic fibrosis: where are we now? Source: Breathe 2014; 10: 34-47 Year: 2014 Cystic fibrosis related pulmonary disease: more structure than function? Source: Eur Respir J 2005; 26: Suppl. 49, 729s Year: 2005 Idiopathic pulmonary fibrosis: a treatable disease? Source: Eur Respir J 2003 Dec 01;22(6):872-873 Year: 2003 Elucidating progression of early cystic fibrosis lung disease Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017 Year: 2017 Aspergillus-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease? Source: Eur Respir Rev, 30 (162) 210103; 10.1183/16000617.0103-2021 Year: 2021 Factors affecting progression of lung disease among patients with cystic fibrosis Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Evolution of the infectious disease in cystic fibrosis (CF) Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008 Cystic interstitial lung disease - a rare disease? Source: International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease Year: 2015 Endotrophin is related to disease progression in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 How much genotype influences cystic fibrosis associated liver disease? Source: Eur Respir J 2006; 28: Suppl. 50, 717s Year: 2006 Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017 Year: 2018 Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018 Year: 2018 A model for active and healthy ageing with a rare genetic disease: cystic fibrosis Source: Eur Respir J 2016; 47: 714-719 Year: 2016 Cystic fibrosis and bone disease: are we missing a genetic link? Source: Eur Respir J 2005; 25: 9-11 Year: 2005 Early determinants of lung disease in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019 Year: 2020 Lung inflammation in cystic fibrosis: an overlooked therapeutic target? Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age Year: 2020 Risk factors for progression of cystic fibrosis lung disease from childhood to adulthood Source: Virtual Congress 2020 – Respiratory diseases in children and adults Year: 2020 Cystic fibrosis a contagious disease. Need for segregation Source: Annual Congress 2005 - Paediatric year in review Year: 2005